These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25983027)

  • 21. Optical coherence tomography in unprotected left main coronary artery stenting.
    Parodi G; Maehara A; Giuliani G; Kubo T; Mintz GS; Migliorini A; Valenti R; Carrabba N; Antoniucci D
    EuroIntervention; 2010 May; 6(1):94-9. PubMed ID: 20542803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
    Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
    J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stent malapposition, strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction.
    Leone AM; Rebuzzi AG; Burzotta F; De Maria GL; Gardi A; Basile E; Cialdella P; D'Amario D; Paraggio L; Porto I; Aurigemma C; Niccoli G; Trani C; Crea F
    J Cardiovasc Med (Hagerstown); 2019 Mar; 20(3):122-130. PubMed ID: 30601191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-centre experience of STENTYS Xposition S in treatment of left main stem lesions.
    Kumar N; Kandan SR; Rahbi H; Mozid A; Johnson TW; Strange JW; Baumbach A
    Expert Rev Med Devices; 2017 Jul; 14(7):577-582. PubMed ID: 28621162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of Stentys Xposition S self-apposing sirolimus eluting stent expansion and apposition with coronary lesion debulking strategy utilizing cutting balloon.
    Yew KL
    Int J Cardiol; 2016 Jan; 203():1007-8. PubMed ID: 26630622
    [No Abstract]   [Full Text] [Related]  

  • 29. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis.
    Magro M; Wykrzykowska J; Serruys PW; Simsek C; Nauta S; Lesiak M; Stanislawska K; Onuma Y; Regar E; van Domburg RT; Grajek S; Geuns RJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):798-806. PubMed ID: 20824767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial.
    Weisz G; Metzger DC; Liberman HA; O'Shaughnessy CD; Douglas JS; Turco MA; Mehran R; Gershony G; Leon MB; Moses JW
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):352-9. PubMed ID: 22927100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
    Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
    JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focus on STENTYS
    Pellegrini D; Cortese B
    Future Cardiol; 2019 May; 15(3):145-159. PubMed ID: 31023079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
    Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U
    EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APPOSITION V: STENTYS coronary stent system clinical trial in subjects with ST-segment elevation myocardial infarction--rationale and design.
    Grundeken MJ; Lu H; Mehran R; Cutlip DE; Leon MB; Yeung A; Koch KT; Montalescot G; van Geuns RJ; Spaargaren R; Buchbinder M
    Am Heart J; 2014 Nov; 168(5):652-60. PubMed ID: 25440792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non-ST-Segment-Elevation Myocardial Infarction (OCTACS) Trial: Difference in Strut Coverage and Dynamic Malapposition Patterns at 6 Months.
    Antonsen L; Thayssen P; Maehara A; Hansen HS; Junker A; Veien KT; Hansen KN; Hougaard M; Mintz GS; Jensen LO
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002446. PubMed ID: 26253735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction.
    van Geuns RJ; Tamburino C; Fajadet J; Vrolix M; Witzenbichler B; Eeckhout E; Spaulding C; Reczuch K; La Manna A; Spaargaren R; García-García HM; Regar E; Capodanno D; Van Langenhove G; Verheye S
    JACC Cardiovasc Interv; 2012 Dec; 5(12):1209-19. PubMed ID: 23257368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
    Tamburino C; La Manna A; Di Salvo ME; Sacchetta G; Capodanno D; Mehran R; Dangas G; Corcos T; Prati F
    JACC Cardiovasc Interv; 2009 Mar; 2(3):197-204. PubMed ID: 19463426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry.
    Agostoni P; Foley D; Lesiak M; Belkacemi A; Dens J; Kumsars I; Scott B; Oemrawsingh P; Dubois C; Garcia E; Lefèvre T; Stella PR
    EuroIntervention; 2012 Mar; 7(11):1293-300. PubMed ID: 22433192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.